A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
about
Gene therapy on the moveNanoparticle ligand presentation for targeting solid tumorsSafety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions.Construction of a tumor cell-targeting non-viral gene delivery vector with polyethylenimine modified with RGD sequence-containing peptide.Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion.Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formationPeptide-Mediated Tumor Targeting by a Degradable Nano Gene Delivery Vector Based on Pluronic-Modified PolyethylenimineD-pinitol inhibits prostate cancer metastasis through inhibition of αVβ3 integrin by modulating FAK, c-Src and NF-κB pathways.Berberine Reduces the Metastasis of Chondrosarcoma by Modulating the α v β 3 Integrin and the PKC δ , c-Src, and AP-1 Signaling Pathways.Intricacies for posttranslational tumor-targeted cytokine gene therapy.Remission of lymphoblastic leukaemia in an intravascular fluidic environment by pliable drug carrier with a sliding target ligand.Applying horizontal gene transfer phenomena to enhance non-viral gene therapyTumor Targeting via Integrin Ligands.Emerging advances in nanomedicine with engineered gold nanostructures.Mesoporous Silica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers.Scaffold and scaffold-free self-assembled systems in regenerative medicine.Peptide-Based and Polypeptide-Based Gene Delivery Systems.Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosis.Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.Synthesis and in vitro photodynamic activities of an integrin-targeting cRGD-conjugated zinc(II) phthalocyanine.Switchable delivery of small interfering RNA using a negatively charged pH-responsive polyethylenimine-based polyelectrolyte complex.Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.Engineering liposomal nanoparticles for targeted gene therapy.Delivery of nucleic acids for cancer gene therapy: overcoming extra- and intra-cellular barriers.Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer.Optimization of Tet1 ligand density in HPMA-co-oligolysine copolymers for targeted neuronal gene delivery.Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid.Molecular design of upconversion nanoparticles for gene delivery.Intracellular microenvironment responsive polymers: a multiple-stage transport platform for high-performance gene delivery.MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression.A Combined NMR and Computational Approach to Determine the RGDechi-hCit-αv β3 Integrin Recognition Mode in Isolated Cell MembranesMixed Peptide-Conjugated Chitosan Matrices as Multi-Receptor Targeted Cell-Adhesive Scaffolds
P2860
Q27007012-80FE3613-DB90-41C0-B371-383D785AC67EQ27009522-0EEAD0B8-E6BD-425C-BB82-6CBCAD864F9CQ34791427-7033E025-C96D-4DB6-AEAB-57B583C04BFEQ35084305-AFA2EA79-8F24-4AE0-B765-6B894F2D37A9Q35403506-D988238B-5F36-4581-A1D8-D494FA472F8EQ35995453-3EF6D34D-F137-4D9C-9B44-29DFDF186757Q36636855-48A13961-8D15-42AD-BE64-25C361E46A52Q36913661-409C16D0-229B-4DF4-B3C4-775EFB4E967CQ37148562-0B66B25A-BBE0-4041-B9FA-A4B3B4CEC7FBQ37392885-BB3E3789-3DDF-480D-82B2-C987FC539B84Q37588983-5814F1B6-B98B-4A47-87AC-D6EEE7B399FCQ38133156-FB598335-CBFD-4935-B85D-0CFB562369ACQ38134759-C4A39C40-1185-45D6-8F6C-391F03E17B1AQ38180306-FD2F1DFE-4C12-4296-A0AF-CDDB50AD6F80Q38296554-28206B34-0ACE-4759-BBAD-153A6CDCABE3Q38615719-54CAC01C-0524-45BD-85F1-71ECE9B8CB2FQ38747732-B0CE69C4-9AB1-4DC2-80B0-7B3D0D4218C3Q38786663-5A2BB10E-DCCA-4232-8AFE-F18471F11FF6Q38988571-1F37084A-5C49-42ED-A1AE-A0C0F6C0B214Q39065986-91C199D4-C205-45E2-8EA3-145CDD13C380Q39189657-3B70B86D-ED76-4509-AC9F-A2B466569D2EQ39216032-30890740-AEBF-452A-8352-4C367FB1985AQ39306702-A74CCE10-EACD-4623-8AF7-41C838E9E5F9Q40599238-7A591B69-FF0E-433D-AB5B-11A63E095FCBQ41709085-A6E9C753-B20E-49BC-82A0-732206B2B90BQ42176649-81D5F3CD-1662-42D4-990F-918B6D066363Q42970633-F959F98B-AFA9-43C6-84D8-813C000BF93FQ44215309-FC1138C1-4E9C-4C85-BF9B-26C9382FD67BQ45218829-F2CA475C-543A-4E25-B685-5941E2F53F34Q51060665-990530FB-2D19-4F81-A3EB-A679608A474DQ57599807-D1BAF928-77B2-4C3F-818F-51DA0C5C2997Q58749421-AF9C57C8-CA08-4724-B5CE-CD252B6B23F8
P2860
A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
@en
type
label
A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
@en
prefLabel
A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2012.64
P50
P577
2012-09-28T00:00:00Z
P6179
1020531647